Skip to Main Content
An official website of the United States government

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Modular approach to comprehensive oncological decision support Daniel Schneider Innovation Center Computer Assisted Surgery, Leipzig University PLCO Jul 22, 2021 PLCO-813
Racial Disparities in Risk Group at Presentation and Access to Treatment for Prostate, Lung, Colorectal and Ovarian Cancer: Insights from the PLCO Cancer Screening Trial Edward Dee Memorial Sloan Kettering Cancer Center PLCO Jul 22, 2021 PLCO-796
Viral exposure signatures in hepatocellular carcinoma Katherine McGlynn National Cancer Institute PLCO Jul 21, 2021 2021-0015
Validation of plasma biomarker panels for the early detection of pancreatic cancer Brian Haab Van Andel Institute PLCO Jul 21, 2021 2021-0017
Using machine learning to understand demographic differences when predicting ovarian cancer Devanshi Kothari Independent PLCO Jul 15, 2021 PLCO-806
Understanding the Persistence Breast Cancer Racial Disparities Kelly Hirko Michigan State University PLCO Jul 15, 2021 PLCO-809
Establishing risk factors for bladder cancer to inform prevention: a pooled analysis of prospective studies from the NCI Cohort Consortium Roger Milne Cancer Council Victoria PLCO Jul 15, 2021 PLCO-810
A Retrospective Study for Construction and Evaluation of Cancer Screening Models from the PLCO Trial: Pancreatic, Prostate, Lung, Colorectal, and Ovarian Cohorts James Long University of Texas MD Anderson Cancer Center PLCO Jul 15, 2021 PLCO-808
System for searching similar patients as supportive tool for clinical decision Anton Kovac Siemens Healthineers PLCO Jul 15, 2021 PLCO-807
Association of sex steroid hormones and biliary tract cancers in men and women Sarah Jackson National Cancer Institute PLCO Jul 13, 2021 2021-0010
Serum concentrations of per- and polyfluoroalkyl substances and breast cancer risk among postmenopausal women: A nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Vicky Chang Occupational and Environmental Epidemiology Branch, DCEG, NCI PLCO Jul 9, 2021 2021-0016
Identifying DNA methylation patterns associated with Multiple Sclerosis Rodney Lea The University of Newcastle PLCO Jul 2, 2021 PLCO-802
An analysis into the association between diet, BMI, diabetes, lifestyle factors and patient demographics on thyroid cancer incidence and mortality. Tharakeswari Selvakumar Rutgers New Jersey Medical School PLCO Jun 21, 2021 PLCO-795
Provide patients with an improved cancer screening recommendation Sebastian Roth Ludwig-Maximilians-Universität Munich - Chair for Mobile and Distributed Systems PLCO Jun 21, 2021 PLCO-798
Validation of prognostic models of lung cancer Thomas Callender University College London PLCO Jun 21, 2021 PLCO-801
Prospective study of DNA repair functional assays and risk of lung cancer Zvi Livneh Weizmann Institute of Science PLCO Jun 14, 2021 2021-0018
Characterizing clonal expansion of large mosaic chromosomal alterations in leukocytes Mitchell Machiela National Cancer Institute PLCO Jun 14, 2021 2021-0014
Using circulating metabolomes to understand pancreatic cancer genotype and phenotype and to explore their potential for risk assessment and early detection Herbert Yu University of Hawaii Cancer Center PLCO Jun 14, 2021 2021-0013
The impact of pregnancy history on genome-wide methylation patterns in women with and without multiple sclerosis Vilija Jokubaitis Monash University PLCO May 21, 2021 PLCO-789
PLCO: Effects of high-dimensional genetic variation (GWAS) on PSA trajectories and their relationship with prostate cancer incidence Grace Hong NCI PLCO May 18, 2021 PLCO-787